# Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease

> **NCT01187992** · PHASE3 · TERMINATED · sponsor: **San Filippo Neri General Hospital** · enrollment: 290 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Coronary Artery Disease

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT01187992
- **Lead sponsor:** San Filippo Neri General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-09
- **Primary completion:** 2007-03
- **Final completion:** 2007-04
- **Target enrollment:** 290 (ACTUAL)
- **Why stopped:** Interim analysis showed significant effect in favour of full-dose atorvastatin.
- **Last updated:** 2010-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01187992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01187992, "Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01187992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*